Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence
Author(s) -
Thomas Santo,
Brodie Clark,
Matthew Hickman,
Jason Grebely,
Gabrielle Campbell,
Luis Sordo,
Aileen B. Chen,
Lucy Thi Tran,
Chrianna Bharat,
Prianka Padmanathan,
Gráinne Cousins,
Julie Dupouy,
Erin Kelty,
Roberto Muga,
Bohdan Nosyk,
Jeong Eun Min,
Raimondo Maria Pavarin,
Michael Farrell,
Louisa Degenhardt
Publication year - 2021
Publication title -
jama psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.531
H-Index - 365
eISSN - 2168-6238
pISSN - 2168-622X
DOI - 10.1001/jamapsychiatry.2021.0976
Subject(s) - medicine , buprenorphine , meta analysis , mortality rate , methadone , population , cohort study , randomized controlled trial , medline , relative risk , systematic review , opioid , confidence interval , psychiatry , environmental health , receptor , political science , law
Mortality among people with opioid dependence is higher than that of the general population. Opioid agonist treatment (OAT) is an effective treatment for opioid dependence; however, there has not yet been a systematic review on the relationship between OAT and specific causes of mortality.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom